Variables influencing Platelet Function Analyzer-100™ closure times in healthy individuals

British Journal of Haematology

Volumn 130, Issue 5, 2005, Pages 759-767

  Haubelt, Hannelore ^a   Anders, Christof ^a   Vogt, Anette ^a   Hoerdt, Petra ^a   Seyfert, Ulrich Theo ^a   Hellstern, Peter ^a  

^a Academic City Hospital   (Germany)

Author keywords

Bleeding time; Platelet function analyzer 100; Platelet function tests; Reference ranges; Von Willebrand factor

Indexed keywords

ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; COLLAGEN;

ADULT; ANALYTICAL EQUIPMENT; ARTICLE; BLEEDING TIME; BLOOD CLOTTING PARAMETERS; BLOOD GROUP O; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LINEAR REGRESSION ANALYSIS; MALE; NORMAL HUMAN; PLATELET FUNCTION ANALYZER 100; PRIORITY JOURNAL; STANDARDIZATION; THROMBOCYTE FUNCTION; BLOOD DONOR; BLOOD SAMPLING; EVALUATION; HEMOSTASIS; INSTRUMENTATION; MASS SCREENING; METHODOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; STATISTICAL MODEL; THROMBOCYTE AGGREGATION;

ADENOSINE DIPHOSPHATE; ADULT; ARACHIDONIC ACID; BLEEDING TIME; BLOOD DONORS; BLOOD SPECIMEN COLLECTION; COLLAGEN; FEMALE; HEMOSTASIS; HUMANS; LINEAR MODELS; MALE; MASS SCREENING; MIDDLE AGED; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEX FACTORS; STATISTICS, NONPARAMETRIC;

EID: 27244434958     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05680.x     Document Type: Article

References (37)

1. Blant J.M. Altman D.G. ( 1986) Statistical methods for assessing agreement between two methods of clinical measurement. The Lancet, 1, 307 310.
2. Böck M. De Haan J. Beck K.H. Gutensohn K. Hertfelder H.J. Karger R. Heim M.U. Beeser H. ( 1999) Standardization of the PFA-100® platelet function test in 105 mmol/l buffered citrate: effect of gender, smoking and oral contraceptives. British Journal of Haematology, 106, 898 904.
3. Brezinski D.A. Tofler G.H. Muller J.E. Pohjola-Sintonen S. Willich S.N. Schafer A.I. Czeisler C.A. Williams G.H. ( 1988) Morning increase in platelet aggregability. Circulation, 78, 35 40.
4. Cariappa R. Wilhite T.R. Parvin C.A. Luchtman-Jones L. ( 2003) Comparison of PFA-100 and bleeding time testing in pediatric patients with suspected hemorrhagic problems. Journal of Pediatric Hematology/Oncology, 25, 474 479.
5. Cattaneo M. Federici A.B. Lecchi A. Lombardi R. Stabile F. Bucciarelli P. ( 1999) Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease. Thrombosis and Haemostasis, 82, 35 39.
6. TM closure time: pivotal role of plasma von Willebrand factor. British Journal of Haematology, 124, 80 85.
7. Dalby M.C. Davidson S.J. Burman J.F. Davies S.W. ( 2000) Diurnal variation in platelet aggregation with the PFA-100 platelet function analyser. Platelets, 11, 320 324.
8. Dean J.A. Blanchette V.S. Carcao M.D. Stain A.M. Sparling C.R. Siekmann J. Turecek P.L. Lillicrap D. Rand M.L. ( 2000) Von Willebrand disease in a pediatric-based population - comparison of type 1 diagnostic criteria and use of the PFA-100® and a von Willebrand factor/collagen-binding assay. Thrombosis and Haemostasis, 84, 401 409.
9. Favarolo E.J. ( 2002) Clinical application of the PFA-100®. Current Opinion in Hematology, 9, 407 415.
10. Francis J. Francis D. Larson L. Helms E. Garcia M. ( 1999) Can the platelet function analyzer (PFA®)-100 test substitute for the template bleeding time in routine clinical practice Platelets, 10, 132 136.
11. Fressinaud E. Veyradier A. Truchaud F. Martin I. Boyer-Neumann C. Troussaert M. Meyer D. ( 1998) Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases. Blood, 91, 1325 1331.
12. Gum P.A. Kottke-Marchant K. Poggio E.D. Gurm H. Welsh P.A. Brooks L. Sapp S.K. Topol E.J. ( 2001) Profile and prevalence of aspirin resistance in patients with cardiovascular disease. American Journal of Cardiology, 88, 230 235.
13. Harrison P. ( 2004) In vitro measurement of high-shear platelet adhesion and aggregation by the PFA-100®. Methods in Molecular Biology, 272, 215 223.
14. Harrison P. Robinson M.S.C. Mackie I.J. Joseph J. McDonald S.J. Liesner R. Savidge G.F. Pasi J. Machin S.J. ( 1999) Performance of the platelet function analyser PFA-100® in testing abnormalities of primary haemostasis. Blood Coagulation and Fibrinolysis, 10, 25 31.
15. Harrison P. Robinson M. Liesner R. Khair K. Cohen H. Mackie I. Machin S. ( 2002) The PFA-100®: a potential rapid screening tool for the assessment of platelet dysfunction. Clinical and Laboratory Haematology, 24, 225 232.
16. Harrison P. Segal H. Furtado C. Verjee S. Sukhu K. Murphy M.F. ( 2004) High incidence of defective high-shear platelet function among platelet donors. Transfusion, 44, 764 770.
17. Haus E. Cusulos M. Sackett-Lundeen L. Swoyer J. ( 1990) Circadian variations in blood coagulation parameters, alpha-antitrypsin antigen and platelet aggregation and retention in clinically healthy subjects. Chronobiology International, 7, 203 216.
18. TM system. Thrombosis Research, 87, 159 64 163.
19. Jilma-Stohlawetz P. Hergovich N. Homoncik M. Dzirlo L. Horvath M. Janisiw M. Panzer S. Jilma B. ( 2001) Impaired platelet function among donors. Thrombosis and Haemostasis, 86, 880 886.
20. Jovicic A. Mandic S. ( 1991) Circadian variation of platelet aggregability and fibrinolytic activity in healthy subjects. Thrombosis Research, 62, 65 74.
21. TM. Seminars in Thrombosis and Hemostasis, 21 ( Suppl. 2 106 112.
22. TM. Clinical and Applied Thrombosis/Hemostasis, 2, 241 249 Manzato F. ( 2001) Influence of the ABO blood type on the platelet function analyzer PFA-100. Thrombosis and Haemostasis, 85, 369 370.
23. Malyszko J. Urano T. Knofler R. Taminato A. Takada Y. Takada A. ( 1994) Daily variations of platelet aggregation in relation to blood and plasma serotonin in diabetes. Thrombosis Research, 75, 569 576.
24. TM system. Seminars in Thrombosis and Hemostasis, 21 ( Suppl. 2 113 121.
25. TM system: a new method for assessment of platelet dysfunction. Seminars in Thrombosis and Hemostasis, 24, 195 202.
26. McKee S.A. Sane D.C. Deliargyris N. ( 2002) Aspirin resistance in cardiovascular disease: a review of prevalence, mechanisms, and clinical significance. Thrombosis and Haemostasis, 88, 711 715.
27. Miller M.E. Thorpe S.L. Dores G.M. ( 1995) Influence of hormones on platelet intracellular calcium. Thrombosis Research, 77, 515 530.
28. Moeller A. Weippert-Kretschmer M. Prinz H. Kretschmer V. ( 2001) Influence of ABO blood groups on primary hemostasis. Transfusion, 41, 56 60.
29. Norris L.A. Devitt M. Bonnar J. ( 1996) The role of thromboxane A2 in increased whole blood platelet aggregation in oral contraceptive users. Thrombosis Research, 81, 407 417.
30. Posan E. McBane R.D. Grill D.E. Motsko C.L. Nichols W.L. ( 2003) Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice. Thrombosis and Haemostasis, 90, 483 490.
31. Quiroga T. Goycoolea M. Munoz B. Morales M. Aranda E. Panes O. Pereira J. Mezzano D. ( 2004) Template bleeding time and PFA-100® have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients. Journal of Thrombosis and Haemostasis, 2, 892 898.
32. Rahmann K. Billington D. ( 2000) dietary supplementation with aged garlic extract inhibits ADP-induced platelet aggregation in humans. Journal of Nutrition, 130, 2662 2665.
33. Saleh A.A. Ginsburg K.A. Duchon T.A. Dorey L.G. Hirata J. Alshameeri R.S. Dombrowski M.P. Mammen E.F. ( 1995) Hormonal contraception and platelet function. Thrombosis Research, 78, 363 367.
34. Schlammadinger A. Kerenyi A. Muszbek L. Boda Z. ( 2000) Comparison of the O'Brien filter test and the PFA-100 platelet analyzer in the laboratory diagnosis of von Willebrand's disease. Thrombosis and Haemostasis, 84, 88 92.
35. Sestito A. Sciahbasi A. Landolfi R. Maseri A. Lanza G.A. Andreotti F. ( 1999) A simple assay for platelet-mediated hemostasis in flowing whole blood (PFA-100): reproducibility and effects of sex and age. Cardiologica, 44, 661 665.
36. Tofler H. Brezinski D. Schafer A.I. Czeisler C.A. Rutherford J.D. Willich S.N. Gleason R.E. Williams G.H. Muller J.E. ( 1987) Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. New England Journal of Medicine, 316, 1514 1518.
37. Wuillemin W.A. Gasser K.M. Zeerleder S.S. Lämmle B. ( 2002) Evaluation of a platelet function analyser (PFA-100®) in patients with a bleeding tendency. Swiss Medical Weekly, 132, 443 448.